Parathyroid adenomas are benign neoplasms with a predilection for the inferior parathyroid glands. Genetic mutations identified as contributing to development of parathyroid adenomas include MEN 1 and cyclin D1. Predisposing factors include female gender and radiation exposure. The natural history of parathyroid adenomas, including malignant potential, is poorly understood. Specific indications for surgical removal in addition to surgical and non surgical therapeutic modalities are discussed in this review. [Arch Clin Exp Surg 2014; 3(4.000): 240-246
Abstract We report nine mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in sporadi...
Parathyroid carcinoma (PC) is a rare endocrine malignancy, accounting for <1% of all cases of sporad...
Hyperparathyroidism occurs in 20-30 % of MEN2A syndrome patients. It is usually associated with mild...
The molecular basis of both benign and malignant parathyroid neoplasia is still poorly understood. W...
The molecular pathogenesis of parathyroid adenomas has yet to be fully elucidated with only two gene...
Parathyroid tumors are rare endocrine neoplasms affecting 0.1–0.3% of the general population, includ...
Atypical parathyroid adenomas represent a group of intermediate form of parathyroid neoplasms of unc...
The molecular basis of both benign and malignant parathyroid neoplasia is still poorly understood. W...
Parathyroid carcinoma (PC) is a rare neoplasia difficult to diagnose preoperatively. It mainly occur...
Parathyroid disease and tumor formation can occur both as a primary process and as a complication of...
Primary hyperparathyroidism (PHPT), due to parathyroid tumours, may occur as part of a complex syndr...
AbstractParathyroid carcinoma is a rare endocrine malignancy. The reported incidence is from 0.5 to ...
Parathyroid carcinoma (PC) is an uncommon finding, accounting for only 1-2% of patients with primary...
Our identification and cloning of the novel cyclin PRAD1 began with the aim of characterizing a para...
The overall goal of this thesis has been to identify new genes and characterize them regarding the i...
Abstract We report nine mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in sporadi...
Parathyroid carcinoma (PC) is a rare endocrine malignancy, accounting for <1% of all cases of sporad...
Hyperparathyroidism occurs in 20-30 % of MEN2A syndrome patients. It is usually associated with mild...
The molecular basis of both benign and malignant parathyroid neoplasia is still poorly understood. W...
The molecular pathogenesis of parathyroid adenomas has yet to be fully elucidated with only two gene...
Parathyroid tumors are rare endocrine neoplasms affecting 0.1–0.3% of the general population, includ...
Atypical parathyroid adenomas represent a group of intermediate form of parathyroid neoplasms of unc...
The molecular basis of both benign and malignant parathyroid neoplasia is still poorly understood. W...
Parathyroid carcinoma (PC) is a rare neoplasia difficult to diagnose preoperatively. It mainly occur...
Parathyroid disease and tumor formation can occur both as a primary process and as a complication of...
Primary hyperparathyroidism (PHPT), due to parathyroid tumours, may occur as part of a complex syndr...
AbstractParathyroid carcinoma is a rare endocrine malignancy. The reported incidence is from 0.5 to ...
Parathyroid carcinoma (PC) is an uncommon finding, accounting for only 1-2% of patients with primary...
Our identification and cloning of the novel cyclin PRAD1 began with the aim of characterizing a para...
The overall goal of this thesis has been to identify new genes and characterize them regarding the i...
Abstract We report nine mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in sporadi...
Parathyroid carcinoma (PC) is a rare endocrine malignancy, accounting for <1% of all cases of sporad...
Hyperparathyroidism occurs in 20-30 % of MEN2A syndrome patients. It is usually associated with mild...